ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.508,67
1,09%
S&P 500
5.127,79
1,26%
US Dollar vs BRL
5,0725
0,00%
Bitcoin
62.705,85
-0,28%
Brent Oil
82,765
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Predictive Oncology Inc (POAI)

  7. Predictive Oncology Inc (POAI) Notícias

POAI

Predictive Oncology (POAI)

Predictive Oncology Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:POAI
DataHoraFonteTítuloCódigoCompanhia
08/02/202419:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:POAIPredictive Oncology Inc
07/12/202310:54Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:POAIPredictive Oncology Inc
05/12/202318:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:POAIPredictive Oncology Inc
13/11/202319:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:POAIPredictive Oncology Inc
04/10/202318:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:POAIPredictive Oncology Inc
15/05/202318:15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:POAIPredictive Oncology Inc
12/05/202319:42Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:POAIPredictive Oncology Inc
02/05/202318:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:POAIPredictive Oncology Inc
18/04/202307:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:POAIPredictive Oncology Inc
17/04/202319:00GlobeNewswire Inc.Predictive Oncology Adjourns Special Meeting of StockholdersNASDAQ:POAIPredictive Oncology Inc
05/04/202314:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:POAIPredictive Oncology Inc
29/03/202318:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:POAIPredictive Oncology Inc
17/03/202318:11Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:POAIPredictive Oncology Inc
16/03/202318:15GlobeNewswire Inc.Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common StockNASDAQ:POAIPredictive Oncology Inc
16/03/202318:11Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:POAIPredictive Oncology Inc
09/03/202310:30GlobeNewswire Inc.Predictive Oncology Issues Letter to ShareholdersNASDAQ:POAIPredictive Oncology Inc
28/02/202319:31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:POAIPredictive Oncology Inc
23/02/202310:30GlobeNewswire Inc.Predictive Oncology and Cvergenx announce partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligenceNASDAQ:POAIPredictive Oncology Inc
21/02/202310:30GlobeNewswire Inc.Predictive Oncology launches ACE program to partner with academic and research institutions to advance their drug discovery initiativesNASDAQ:POAIPredictive Oncology Inc
03/02/202310:31GlobeNewswire Inc.Predictive Oncology Appoints Pamela Bush, Ph.D., MBA, as Chief Business OfficerNASDAQ:POAIPredictive Oncology Inc
12/01/202310:30GlobeNewswire Inc.Pioneer of Computational Biology Joins the Scientific Advisory Board of Predictive OncologyNASDAQ:POAIPredictive Oncology Inc
13/12/202210:30GlobeNewswire Inc.Distinguished Innovator in Genomics Joins the Scientific Advisory Board of Predictive OncologyNASDAQ:POAIPredictive Oncology Inc
05/12/202210:30GlobeNewswire Inc.Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of DirectorsNASDAQ:POAIPredictive Oncology Inc
10/11/202219:15GlobeNewswire Inc.Predictive Oncology Reports Third Quarter Financial ResultsNASDAQ:POAIPredictive Oncology Inc
25/10/202209:30GlobeNewswire Inc.David S. Smith appointed to the Board of Directors of Predictive OncologyNASDAQ:POAIPredictive Oncology Inc
20/10/202209:30GlobeNewswire Inc.Predictive Oncology Announces New Chief Executive Officer Raymond F. Vennare to Lead Company GrowthNASDAQ:POAIPredictive Oncology Inc
14/10/202207:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:POAIPredictive Oncology Inc
13/10/202218:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:POAIPredictive Oncology Inc
30/09/202218:07Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:POAIPredictive Oncology Inc
19/09/202209:30GlobeNewswire Inc.Predictive Oncology Strengthens Offerings with GMP Lab and Addition of Leading Expert in Formulation DevelopmentNASDAQ:POAIPredictive Oncology Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:POAI

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
HOOT4
HOTEIS OTHON PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados